Favorable outcomes of front-line risk-adapted therapy in young patients with diffuse large B-cell lymphoma with clinically or biologically high-risk features.
Zou H, Liu W, Wang Y, Shan D, Xie T, Li R, Liu H, Huang W, Fu M, Wang T, Lyu R, Deng S, Sui W, Xu Y, Yi S, An G, Qiu L, Zou D.
Zou H, et al. Among authors: shan d.
Chin Med J (Engl). 2024 Jul 5;137(13):1620-1622. doi: 10.1097/CM9.0000000000002940. Epub 2023 Dec 7.
Chin Med J (Engl). 2024.
PMID: 38061986
Free PMC article.
No abstract available.